Susan T. Hager

Susan T. Hager

Corporate Officer/Principal chez
National Investor Relations Institute
Health Technology
Commercial Services
Process Industries

Profil

Susan T.
Hager
is currently the Co-Chairman-GreenBio Task Force at Massachusetts Biotechnology Council and a Member at National Investor Relations Institute.
She was previously the Corporate Director at Real Chemistry, Inc., Head-Corporate & Investor Relations at Oncotelic Therapeutics, Inc., VP-Investor Relations & Corporate Communications at Coley Pharmaceutical Group, Inc., VP-Investor Relations & Corporate Communications at Targanta Therapeutics Corp., SVP-Corporate Communications & Government Affairs at PTTGC Innovation America Corp., VP-Corporate Communications & Government Affairs at Qteros, Inc., and Senior Manager-Global Communications at Bayer HealthCare.
She was also the SVP-Corporate Communications & Government Affairs at Foundation Medicine, Inc. from 2014 to 2019.
Ms. Hager received her undergraduate and MBA degrees from Northeastern University.

Postes actifs de Susan T. Hager

SociétésPosteDébut
Corporate Officer/Principal -
Corporate Officer/Principal -

Anciens postes connus de Susan T. Hager

SociétésPosteFin
FOUNDATION MEDICINE INC Public Communications Contact 01/06/2019
Public Communications Contact 01/01/2008
Corporate Officer/Principal -
Public Communications Contact -
Investor Relations Contact -
Voir l'expérience en détail de Susan T. Hager

Formation de Susan T. Hager

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

79

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Process Industries

Consumer Services

Commercial Services

Process Industries

Commercial Services

Health Services

Health Services

Commercial Services

  1. Bourse
  2. Insiders
  3. Susan T. Hager
🔇